Jun 11 |
Inhibrx Biosciences files to sell 2.45M shares of common stock for holders
|
Jun 7 |
Inhibrx: Continued Advancement Even After INBRX-101 Sale To Sanofi
|
May 24 |
Inhibrx gets stockholders approval to sell INBRX-101 to Sanofi
|
May 24 |
Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi
|
May 10 |
Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off
|
May 8 |
Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated Merger
|
Apr 16 |
As more rare disease therapies launch, their prices are rising
|
Feb 28 |
Inhibrx reports Q4 results
|
Feb 28 |
Inhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue Estimates
|
Feb 28 |
Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results
|